The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the security of testosterone. The study included nearly 800 elderly men with low testosterone and symptoms associated with this affliction, for example testosterone therapy before and after (tinyurl.com
) sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.
Research has shown that testosterone deficiency is related to several important health problems like diabetes, obesity, metabolic syndrome, and bone fractures Men who meet medical standards for treatment should get therapy. In fact, your testosterone levels have probably been slowly decreasing for quite some time, a downfall that usually begins around age 30.
And many women have a knee jerk feeling that any hormone treatment
can raise their risk of breast cancer. However, clinical studies demonstrate that testosterone
not only does not raise a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will likely stay the status quo for a little while, given the prohibitive cost of conducting the long-term safety studies needed to acquire FDA approval that is fuller.